Pharma

By Jonah Comstock August 17, 2017
UCB, a global pharmaceutical company, is partnering with Belgian American health startup Byteflies to use the startup's wearable sensors to monitor seizures. Byteflies makes a customizable wearable device for the pharma and healthcare industries called Sensor Dot. It's a quarter-sized sensor that can be worn around the wrist or attached anywhere on the body as a patch. It's capable of measuring ...
By Jeff Lagasse August 2, 2017
Personal genetics company 23andMe will be teaming up with the Milken Institute, a think tank, and pharmaceutical company Lundbeck to drive enrollment for a genetic study designed to grasp the underlying biology of major depressive and bipolar disorders.   The study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes -- such as...
By Jeff Lagasse August 1, 2017
Medicines aren’t the only tools that biopharma companies like Sanofi are using to help patients. Information technology has become a key tool in every part of Sanofi’s business, and among the most important digital tools are data and analytics; they enable the company to apply insights gained from real world evidence to the discovery, development and delivery of new medicines.   To advance that...
By Jonah Comstock July 25, 2017
Senseonics and TypeZero's R&D partnership around the artificial pancreas is leveling up. The two organizations announced today that they would team up with pharmaceutical and medical device company Roche to launch three European clinical trials of their combined closed-loop system. The research is backed by the National Institutes of Health (NIH) through its International Diabetes Closed Loop...
By Jeff Lagasse July 17, 2017
Abbott and Bigfoot Biomedical have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions.    Under the agreement, Abbott will supply glucose measurement sensors for all of Bigfoot's insulin delivery systems in the U.S. as the exclusive sensors for those systems...
By Jeff Lagasse July 17, 2017
Novo Nordisk and Glooko are working together to help people manage diabetes from their phones. The companies have partnered on the Cornerstones4Care Powered by Glooko, an app melding Novo Nordisk’s knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics know-how. The idea behind the app is to provide, for people with diabetes, a means of measuring...
By Jonah Comstock July 14, 2017
In Q2 2017, we continued to see more pharma companies step up their efforts in digital health, from app launches to FDA clearances to wearable usage in clinical trials. Read on below for a summary of those moves. In a move that could have growing significance for pharma going forward, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership of pharma companies, academics...
By Heather Mack July 11, 2017
With all the recent technological approaches to clinical trials as of late, it’s clear that the notoriously long, expensive and often inefficient traditional process could use an update. From AI-powered matching platforms to increasingly sophisticated software to streamline data collection during trials, the space is getting busier. Palo Alto-based monARC Bionetworks is one of the latest to make...
By Heather Mack June 30, 2017
The relationship between global pharmaceutical company Roche and digital diabetes management app maker mySugr has been growing for the past couple of years. First there was the investment, then there was the partnership, and now Roche is going all in and becoming the exclusive shareholder of mySugr.  Under the agreement, mySugr will continue to function as a separate legal entity, but will serve...
By Heather Mack June 29, 2017
Life sciences consulting firm Parexel is teaming up with Sanofi to research the role of wearables in clinical trials. While sensor-enabled devices have increasingly featured in a variety of research projects and studies, their efficacy and accuracy remains a point of debate, and Parexel and Sanofi hope to investigate that question. Together, Sanofi and Parexel are leveraging their respective...

Editor's Pick